Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Allotment of ESOP under Jagsonpal Pharmaceuticals Limited ESOP Plan, 2022'.
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals has allotted 53,000 equity shares (face value Rs. 2 each) to eligible employees under the Jagsonpal Pharmaceuticals Limited ESOP Plan, 2022, upon exercise of vested stock options. The shares were issued at three different exercise prices: Rs. 94 for 35,500 shares, Rs. 113.6 for 13,900 shares, and Rs. 115.6 for 3,600 shares. As a result, the company's paid-up share capital has risen from Rs. 13.29 crore to Rs. 13.30 crore, with total equity shares now standing at 6,65,26,480. The newly issued shares will rank equally with existing shares and carry no lock-in restrictions.
This is a minor equity dilution of about 0.008% and is unlikely to have any material impact on the stock price. The allotment reflects routine exercise of employee stock options, indicating ongoing employee incentivisation.